中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2016, 28(4): 470-474
微小RNA与宫颈癌
熊焱强,王 玎,李志英*
(三峡大学仁和医院妇产科,宜昌 443002)
摘 要:微小RNA (microRNA, miRNA) 在宫颈癌的发生、侵袭、转移和复发等过程中扮演重要角色,与其预后密切相关。它能在组织、血清和血浆等标本中稳定存在,可通过调控靶基因从而促进宫颈癌细胞凋亡,并能改变宫颈癌细胞对药物和射线的敏感性,这使得miRNA 有望成为一种与宫颈癌诊疗密切相关的新型分子标志物。就miRNA 在宫颈癌的早期分子诊断、治疗以及预后判断等方面的最新研究进展作一综述。
 
MicroRNA and cervical cancer
XIONG Yan-Qiang, WANG Ding, LI Zhi-Ying*
(Department of Gynaecology and Obstetrics, Ren-he Hospital, China Three Gorges University, Yichang 443002, China)
Abstract: microRNA (miRNA) plays an important role in the occurrence, invasion, metastasis and recurrence of cervical cancer, which is closely related to the prognosis of cervical cancer. MiRNAs can not only exist stably in tissue, serum and plasma, but also promote cervical cancer cell apoptosis and change drug and radiation sensitivity of cervical cancer cell line through regulating target genes. Since miRNA is closely related to cervical cancer diagnosis and treatment, it is expected to be a new kind of molecular marker. This article reviews the latest research progress in molecular diagnosis, treatment and prognosis of miRNAs in the early stage of cervical cancer.
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第3063199 位访问者,欢迎!